AI In Oncology Market Size, Share & Trends Report

AI In Oncology Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Cancer Type, By Treatment Type, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-985-7
  • Number of Pages: 80
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2020
  • Industry: Healthcare

Market Segmentation 

  • AI in Oncology Component Outlook (Revenue, USD Million, 2016 - 2030)
    • Software Solutions
    • Hardware
    • Services
  • AI in Oncology Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Brain Tumor
    • Others
  • AI in Oncology Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
    • Chemotherapy
    • Radiotherapy
    • Immunotherapy
    • Others
  • AI in Oncology Regional Outlook (Revenue, USD Million, 2016 - 2030)
    • North America
      • North America Component Outlook (Revenue, USD Million, 2016 - 2030)
        • Software Solutions
        • Hardware
        • Services
      • North America Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
        • Breast Cancer
        • Lung Cancer
        • Prostate Cancer
        • Colorectal Cancer
        • Brain Tumor
        • Others
      • North America Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
        • Chemotherapy
        • Radiotherapy
        • Immunotherapy
        • Others
      • U.S.
        • U.S. Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • U.S. Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • U.S. Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • Canada
        • Canada Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Canada Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Canada Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
    • Europe
      • Europe Component Outlook (Revenue, USD Million, 2016 - 2030)
        • Software Solutions
        • Hardware
        • Services
      • Europe Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
        • Breast Cancer
        • Lung Cancer
        • Prostate Cancer
        • Colorectal Cancer
        • Brain Tumor
        • Others
      • Europe Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
        • Chemotherapy
        • Radiotherapy
        • Immunotherapy
        • Others
      • Germany
        • Germany Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Germany Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Germany Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • U.K.
        • U.K. Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • U.K. Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • U.K. Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • France
        • France Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • France Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • France Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • Italy
        • Italy Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Italy Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Italy Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • Spain
        • Spain Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Spain Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Spain Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • Russia
        • Russia Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Russia Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Russia Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
    • Asia Pacific
      • Asia Pacific Component Outlook (Revenue, USD Million, 2016 - 2030)
        • Software Solutions
        • Hardware
        • Services
      • Asia Pacific Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
        • Breast Cancer
        • Lung Cancer
        • Prostate Cancer
        • Colorectal Cancer
        • Brain Tumor
        • Others
      • Asia Pacific Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
        • Chemotherapy
        • Radiotherapy
        • Immunotherapy
        • Others
      • Japan
        • Japan Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Japan Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Japan Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • China
        • China Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • China Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • China Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • India
        • India Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • India Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • India Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • Australia
        • Australia Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Australia Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Australia Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • South Korea
        • South Korea Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • South Korea Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • South Korea Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
    • Latin America
      • Latin America Component Outlook (Revenue, USD Million, 2016 - 2030)
        • Software Solutions
        • Hardware
        • Services
      • Latin America Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
        • Breast Cancer
        • Lung Cancer
        • Prostate Cancer
        • Colorectal Cancer
        • Brain Tumor
        • Others
      • Latin America Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
        • Chemotherapy
        • Radiotherapy
        • Immunotherapy
        • Others
      • Brazil
        • Brazil Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Brazil Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Brazil Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • Mexico
        • Mexico Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Mexico Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Mexico Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • Argentina
        • Argentina Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Argentina Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Argentina Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
    • MEA
      • MEA Component Outlook (Revenue, USD Million, 2016 - 2030)
        • Software Solutions
        • Hardware
        • Services
      • MEA Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
        • Breast Cancer
        • Lung Cancer
        • Prostate Cancer
        • Colorectal Cancer
        • Brain Tumor
        • Others
      • MEA Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
        • Chemotherapy
        • Radiotherapy
        • Immunotherapy
        • Others
      • South Africa
        • South Africa Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • South Africa Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • South Africa Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • Saudi Arabia
        • Saudi Arabia Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • Saudi Arabia Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • Saudi Arabia Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others
      • UAE
        • UAE Component Outlook (Revenue, USD Million, 2016 - 2030)
          • Software Solutions
          • Hardware
          • Services
        • UAE Cancer Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Breast Cancer
          • Lung Cancer
          • Prostate Cancer
          • Colorectal Cancer
          • Brain Tumor
          • Others
        • UAE Treatment Type Outlook (Revenue, USD Million, 2016 - 2030)
          • Chemotherapy
          • Radiotherapy
          • Immunotherapy
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2016 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon